GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chunghwa Chemical Synthesis & Biotech Co Ltd (TPE:1762) » Definitions » Cyclically Adjusted Price-to-FCF

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Cyclically Adjusted Price-to-FCF : (As of Jun. 05, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Price-to-FCF Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Chunghwa Chemical Synthesis & Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.952/134.9266*134.9266
=0.952

Current CPI (Mar. 2025) = 134.9266.

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.600 100.684 0.804
201509 0.171 100.392 0.230
201512 0.045 99.792 0.061
201603 0.621 100.470 0.834
201606 0.117 101.688 0.155
201609 0.151 101.861 0.200
201612 0.989 101.863 1.310
201703 0.354 102.862 0.464
201706 -1.072 103.349 -1.400
201709 -2.278 104.136 -2.952
201712 -5.276 104.011 -6.844
201803 1.663 105.290 2.131
201806 0.276 106.317 0.350
201809 -0.044 106.507 -0.056
201812 -0.089 105.998 -0.113
201903 0.209 107.251 0.263
201906 1.029 108.070 1.285
201909 0.218 108.329 0.272
201912 0.492 108.420 0.612
202003 0.167 108.902 0.207
202006 0.632 108.767 0.784
202009 -0.927 109.815 -1.139
202012 -0.557 109.897 -0.684
202103 1.254 111.754 1.514
202106 -2.293 114.631 -2.699
202109 -1.247 115.734 -1.454
202112 -0.106 117.630 -0.122
202203 0.801 121.301 0.891
202206 2.302 125.017 2.484
202209 0.958 125.227 1.032
202212 0.516 125.222 0.556
202303 -3.974 127.348 -4.211
202306 1.275 128.729 1.336
202309 -3.772 129.860 -3.919
202312 -0.113 129.419 -0.118
202403 -3.401 131.776 -3.482
202406 5.254 132.554 5.348
202409 0.573 133.029 0.581
202412 2.258 133.157 2.288
202503 0.952 134.927 0.952

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.

Chunghwa Chemical Synthesis & Biotech Co Headlines

No Headlines